Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Nephrology|August 6, 2025
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipientsT Van Meerhaeghe, J F Baurain, O Bechter, et al.
Frontiers in Nephrology|September 7, 2023
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipientsT Van Meerhaeghe, J F Baurain, O Bechter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2014
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trialS Leyvraz, S Piperno-Neumann, S Suciu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape studyJ-P Machiels, L Duck, B Honhon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2023
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysisJ M Piulats, C Watkins, M Costa-García, et al.
ESMO Open|March 2, 2023
Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastasesJ R Hecht, S S Raman, A Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2018
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)A Marabelle, R Andtbacka, K Harrington, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
BMC Cancer|May 21, 2021
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort studyC van Marcke, N Honoré, A van der Elst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal MelanomaS Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Pageof 3